Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000258368

Medchemexpress LLC Roginolisib hemifumarate | 1621688-31-0 | 99.8% | C26H27FN4O5S.1/2C4H4O4 | 10MG
SDP

Supplier:  Medchemexpress LLC HY135827A10MG

Encompass_Preferred

Roginolisib hemifumarate is an orally active, selective PI3Kδ inhibitor used in preclinical and clinical research. It acts via a non-ATP-competitive mechanism with a reported IC50 around 145 nM and demonstrates high selectivity across a broad kinase panel. The compound is supplied as the hemifumarate salt and is intended for biochemical and cellular studies (research use only).

  • Selective PI3Kδ inhibition with reported IC50 ≈145 nM.
  • High selectivity versus a broad panel of kinases.
  • Orally active profile suitable for in vivo research.
  • Supplied as a hemifumarate salt for consistent formulation.
  • High purity appropriate for biochemical and cellular assays.

Catalog No. 50-002-58368


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.